Table 7 30-day clinical outcomes
Variables | Total population | Propensity-matched population | ||||||
|---|---|---|---|---|---|---|---|---|
Suboptimal flow (n = 245) | Optimal flow (n = 859) | Unadjusted RR (95% CI) | P value | Suboptimal flow (n = 214) | Optimal flow (n = 214) | Adjusted RR (95% CI) | P value | |
MACE, n (%) | 34 (13.9) | 52 (6.1) | 2.416 (1.522–3.833) | < 0.001 | 29 (13.6) | 14 (6.5) | 2.021 (1.097–3.535) | 0.025 |
Mortality (cardiac), n (%) | 18 (7.3) | 19 (2.2) | 3.506 (1.810–6.790) | < 0.001 | 15 (7.0) | 5 (2.3) | 2.931 (1.073–7.442) | 0.031 |
Re-infarction, n (%) | 18 (7.3) | 30 (3.5) | 2.118 (1.163–3.856) | 0.014 | 17 (7.9) | 8 (3.7) | 2.060 (0.905–4.438) | 0.108 |
Revascularization, n (%) | 15 (6.1) | 28 (3.3) | 1.936 (1.017–3.685) | 0.044 | 14 (6.5) | 6 (2.8) | 2.271 (0.889–5.465) | 0.115 |
Ischemic stroke, n (%) | 1 (0.4) | 3 (0.3) | 1.169 (0.122–11.185) | 0.892 | 1 (0.5) | 0 (0) | NA | 0.995 |
Cardiogenic shock, n (%) | 33 (13.5) | 45 (5.2) | 2.829 (1.761–4.545) | < 0.001 | 25 (11.7) | 12 (5.6) | 2.061 (1.040–3.852) | 0.039 |
Heart Failure, n (%) | 84 (34.3) | 164 (19.1) | 2.211 (1.615–3.026) | < 0.001 | 69 (32.2) | 48 (22.4) | 1.412 (1.024–1.866) | 0.036 |
Malignant arrhythmias, n (%) | 42 (17.1) | 88 (10.2) | 1.813 (1.217–2.701) | 0.003 | 37 (17.3) | 20 (9.3) | 1.850 (1.119–2.914) | 0.017 |
Bradyarrhythmias, n (%) | 27 (11.0) | 65 (7.6) | 1.513 (0.943–2.428) | 0.084 | 22 (10.3) | 19 (8.9) | 1.143 (0.629–1.997) | 0.655 |
Bleeding, n (%) | 14 (5.7) | 34 (4.0) | 1.471 (0.776–2.787) | 0.237 | 10 (4.7) | 7 (3.3) | 1.360 (0.517–3.417) | 0.529 |